- Home
- VRCA vs GROW Comparison
VRCA vs GROW Comparison
Compare VRCA & GROW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | VRCA | GROW |
|---|---|---|
| Founded | 2013 | 1968 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 32.7M | 31.3M |
| IPO Year | 2018 | N/A |
Fundamental Metrics
Financial Performance| Metric | VRCA | GROW |
|---|---|---|
| Price | $7.24 | $2.52 |
| Analyst Decision | Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $17.00 | N/A |
| AVG Volume (30 Days) | ★ 192.6K | 56.9K |
| Earning Date | 03-10-2026 | 02-11-2026 |
| Dividend Yield | N/A | ★ 3.63% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.07 |
| Revenue | ★ $30,829,000.00 | $8,546,000.00 |
| Revenue This Year | $373.20 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $38.03 |
| Revenue Growth | ★ 234.73 | N/A |
| 52 Week Low | $3.28 | $2.02 |
| 52 Week High | $9.82 | $2.78 |
Technical Indicators
Market Signals| Indicator | VRCA | GROW |
|---|---|---|
| Relative Strength Index (RSI) | 43.04 | 58.01 |
| Support Level | $7.79 | $2.43 |
| Resistance Level | $8.20 | $2.61 |
| Average True Range (ATR) | 0.59 | 0.08 |
| MACD | -0.20 | 0.01 |
| Stochastic Oscillator | 1.38 | 69.57 |
Price Performance
Historical ComparisonAbout VRCA Verrica Pharmaceuticals Inc.
Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases. Its product candidate, VP-102, is developed for the treatment of molluscum contagiosum, or molluscum, a contagious and pediatric viral skin disease, and common warts.
About GROW U.S. Global Investors Inc.
US Global Investors Inc is a registered investment advisory firm. The company manages the following business segments: Investment management services; through which the company offers, to U.S. Global Investors Funds (USGIF or the Funds) and exchange-traded fund (ETF) clients, a range of investment management products and services to meet the needs of individual and institutional investors; and Corporate Investments, through which the company invests for its own account in an effort to add growth and value to its cash position. It derives all its revenue from Investment management services.